María Lagarde
Universidad Complutense de Madrid(ES)Instituto de Salud Carlos III(ES)Cegep de Saint Hyacinthe(CA)Research Institute Hospital 12 de Octubre(ES)Centro de Investigación en Red en Enfermedades Cardiovasculares(ES)Biogipuzkoa Health Research Institute(ES)Hospital Universitario 12 De Octubre(ES)Centre for Biomedical Network Research on Rare Diseases(ES)Centro de Investigación Biomédica en Red(ES)Medical Research Network(US)Universidad Autónoma de Madrid(ES)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Hepatitis C virus research, HIV-related health complications and treatments
Most-Cited Works
- → Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial(2017)102 cited
- → Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin(2013)66 cited
- → Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia(2013)62 cited
- → Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)(2018)60 cited
- → Changes in Liver Steatosis After Switching From Efavirenz to Raltegravir Among Human Immunodeficiency Virus–Infected Patients With Nonalcoholic Fatty Liver Disease(2017)56 cited